Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2021 April;112(2) > Minerva Medica 2021 April;112(2):310-2

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Minerva Medica 2021 April;112(2):310-2

DOI: 10.23736/S0026-4806.19.06236-0

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Efficacy and safety of cyclophosphamide, doxorubicin, vincristine, and prednisone regimen with pegylated liposomal doxorubicin±rituximab in treating diffuse large B-cell lymphoma

Yuhuan GAO 1, Yan XIE 2, Lihong LIU 1, Hongwei XUE 3, Ming HOU 4, Mingzhi ZHANG 5, Zeping ZHOU 6, Pengxiang GUO 7, Hongxia YAO 8, Zonghong SHAO 9, Xiaobao XIE 10, Jun ZHU 2


To access the FULL TEXT of this article choose one of the two following options:

PURCHASE THE ARTICLE

You can access the full text of this article (PDF and HTML if available) for 2 days at a price of:  € 10,00.

INDIVIDUAL SUBSCRIBERS/MEMBERS LOGIN


TO SUBSCRIBE

top of page